-
Is Gilead’s new once-a-day, four-in-one AIDS med worth $78 a pill?
Gilead’s four-drug combo pill, taken just once a day, clearly is an innovation. But is it really 140 times more valuable than a generic approach?
-
Hospitals, MedCity Influencers, Pharma, Policy
Maybe it’s time to put a dollar value on end-of-life treatments
Instead of having a binary option of either not allowing Medicare to pay for the drug or paying $10,000 a month, why not simply set the price that Medicare will pay at its actual value? If the drug company continues to insist on charging more, then people will have to pay the difference out-of-pocket.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Obama’s Medicare revamp plan cuts waste, Romney’s would add 20% copay
Dr. Aaron Carroll at the Incidental Economist blog captures the essence of the GOP platform […]
-
Hospitals, MedCity Influencers, Policy
Hospitals aren’t chain restaurants. That’s why they need big government regulation
Atul Gawande of The New Yorker has another breakthrough article, this time on improving quality […]
-
Public officials deserve credit for exposing anemia drug dangers
As a long-time observer of the Amgen/Epo saga (Ye gads, did I really write my […]
-
If universal healthcare isn’t a priority for either party, how will everyone get coverage?
For the time being, the United States’ long slog toward universal health insurance coverage remains […]
-
Why health insurance reform will survive the loss of the individual mandate
The Supreme Court’s imminent decision on the Affordable Care Act will trigger a political firestorm […]
-
Devices & Diagnostics, MedCity Influencers, Policy
Device firms complain about jobs to keep attention away from great margins, opaque pricing
Ignoring threats of a presidential veto, House Republicans earlier this month repealed the medical device […]
-
Hospitals, MedCity Influencers
Hospice-centric cancer care means less Neupogen and fewer robotic surgeries
Any time you hear someone use the phrase “death panels,” ask them if they are […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
International health groups push patent pool to solve funding problems
Amid a growing crisis in financing treatments for AIDS, tuberculosis and malaria in the developing […]
-
Devices & Diagnostics, MedCity Influencers, Pharma, Policy
Pharma, device firms kill conflict of interest rule, win accelerated approval
Over the angry protests of consumer groups, Congress is moving rapidly – and in bipartisan fashion […]
-
GOP worries that voucher label is dangerous
What’s in a name? Everything, it would appear, when it comes to describing Rep. Paul […]
-
Less Medicare spending: Skimping or smarter management?
Health care spending over the last two years has slowed to levels not seen since […]
-
Devices & Diagnostics, MedCity Influencers
Donor info shows that Medtronic, St. Jude both give to Hauser’s institute
When you take money from everyone, is it no longer a conflict of interest? I […]
-
Latest expansion of Medicaid is smaller than previous growth during Bush
Justice Stephen Breyer seemed unsure of his facts during the recent Affordable Care Act hearings. […]